Endotelialny dysfunction at patients with COPD and coronary heart disease

Irina Demko (Krasnoyarsk, Krasnoyarsk Krai, Russian Federation), Irina Demko, Angelina Kraposhina, Irina Soloveva, Marina Mamaeva, Natalia Gordeeva, Elena Sobko, Alla Salmina

Source: International Congress 2015 – Pulmonary hypertension in lung disease
Session: Pulmonary hypertension in lung disease
Session type: Thematic Poster Session
Number: 3769
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Irina Demko (Krasnoyarsk, Krasnoyarsk Krai, Russian Federation), Irina Demko, Angelina Kraposhina, Irina Soloveva, Marina Mamaeva, Natalia Gordeeva, Elena Sobko, Alla Salmina. Endotelialny dysfunction at patients with COPD and coronary heart disease. Eur Respir J 2015; 46: Suppl. 59, 3769

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014


Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Telomere length in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013


Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Survivin in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD)
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018

Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Circulating desmosine relates to cardiovascular comorbidity, coronary artery calcification score (CACS), systemic inflammation and mortality in patients with COPD
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014

Structural brain changes in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Polymorphism of collagen I gene and risk of chronic obstructive pulmonary disease associated with ischemic heart disease
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014